Effect of Metformin on Peripheral Nerve Morphology in Type 2 Diabetes: A Cross-Sectional Observational Study
Diabetes · 2024
DOI: 10.2337/db24-0365 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Diabetes, 2024. Verfasst von Roshan Dhanapalaratnam und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Metformin, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Hypoglycemic Agents. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetic peripheral neuropathy (DPN) affects ∼50% of the 500 million people with type 2 diabetes worldwide and is considered disabling and irreversible. The current study was undertaken to assess the effect of metformin on peripheral neuropathy outcomes in type 2 diabetes. Participants with type 2 diabetes (n = 69) receiving metformin were recruited and underwent clinical assessment, peripheral nerve ultrasonography, nerve conduction studies, and axonal excitability studies. Also concurrently screened were 318 participants who were not on metformin, and 69 were selected as disease control subjects and matched to the metformin participants for age, sex, diabetes duration, BMI, HbA1c, and use of other diabetes therapies. Medical record data over the previous 20 years were analyzed for previous metformin use. Mean tibial nerve cross-sectional area was lower in the metformin group (metformin 14.1 ± 0.7 mm2, nonmetformin 16.2 ± 0.9 mm2, P = 0.038), accompanied by reduction in neuropathy symptom severity (P = 0.021). Axonal excitability studies demonstrated superior axonal function in the metformin group, and mathematical modeling demonstrated that these improvements were mediated by changes in nodal Na+and K+conductances. Metformin treatment is associated with superior nerve structure and clinical and neurophysiological measures. Treatment with metformin may be neuroprotective in DPN. Article Highlights
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia.
- Department of Neurology, Prince of Wales Hospital, Sydney, New South Wales, Australia.
- Department of Endocrinology, Prince of Wales Hospital, Sydney, New South Wales, Australia.
- School of Medical, Indigenous and Health Sciences, University of Wollongong, Wollongong, New South Wales, Australia.
ORCID-Profile: Roshan Dhanapalaratnam, Tushar Issar, Arun V Krishnan
Zitieren
APA
Dhanapalaratnam, R., Issar, T., Wang, L. L., Tran, D., Poynten, A. M., Milner, K. L., Kwai, N. C. G., & Krishnan, A. V. (2024). Effect of Metformin on Peripheral Nerve Morphology in Type 2 Diabetes: A Cross-Sectional Observational Study. Diabetes. https://doi.org/10.2337/db24-0365
Vancouver
Dhanapalaratnam R, Issar T, Wang LL, Tran D, Poynten AM, Milner KL, et al. Effect of Metformin on Peripheral Nerve Morphology in Type 2 Diabetes: A Cross-Sectional Observational Study. Diabetes. 2024. doi:10.2337/db24-0365
BibTeX
@article{Dhanapalaratnam2024,
author = {Dhanapalaratnam, Roshan and Issar, Tushar and Wang, Leiao Leon and Tran, Darren and Poynten, Ann M and Milner, Kerry-Lee and Kwai, Natalie C G and Krishnan, Arun V},
title = {Effect of Metformin on Peripheral Nerve Morphology in Type 2 Diabetes: A Cross-Sectional Observational Study},
journal = {Diabetes},
year = {2024},
doi = {10.2337/db24-0365}
}
EUVIMED